Purpurogallin

Purpurogallin

SCHEMBL33853

O=c1c(O)cccc2cc(O)c(O)c(O)c12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 2/20 1.00
MEN1 O00255 2/20 1.00
ALDH1A1 P00352 2/20 1.00
KMT2A Q03164 2/20 1.00
MAPT P10636 2/20 1.00
KDM4E B2RXH2 1/20 1.00
INPPL1 O15357 1/20 1.00
NSD2 O96028 1/20 1.00
TP53 P04637 1/20 1.00
POLB P06746 1/20 1.00
CYP3A4 P08684 1/20 1.00
GAA P10253 1/20 1.00
THRB P10828 1/20 1.00
PABPC1 P11940 1/20 1.00
PKM P14618 1/20 1.00
IDO1 P14902 1/20 1.00
HPGD P15428 1/20 1.00
ALOX15 P16050 1/20 1.00
PLCG1 P19174 1/20 1.00
TNNI3 P19429 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Purpurogallin SCHEMBL29481120 1.00 CDK2 (1.00) CDK2MEN1ALDH1A1KMT2AMAPT
Purpurogallin SCHEMBL2839450 0.96 CDK2 (0.93) CDK2MEN1ALDH1A1KMT2AMAPT
Purpurogallin SCHEMBL15560816 0.91 CDK2 (0.83) CDK2MEN1ALDH1A1KMT2AMAPT
Purpurogallin SCHEMBL1950656 0.87 CDK2 (0.76) CDK2MEN1ALDH1A1KMT2AMAPT
Purpurogallin SCHEMBL28319789 0.87 MEN1 (0.76) CDK2MEN1ALDH1A1KMT2AMAPT
SCHEMBL15557274 0.87 CDK2 (0.77) CDK2MEN1ALDH1A1KMT2AMAPT
SCHEMBL24107152 0.83 CDK2 (0.71) CDK2MEN1ALDH1A1KMT2AMAPT
SCHEMBL12610186 0.83 CDK2 (0.71) CDK2MEN1ALDH1A1KMT2AMAPT
SCHEMBL17357502 0.83 ALDH1A1 (0.71) CDK2MEN1ALDH1A1KMT2AMAPT
SCHEMBL6544581 0.83 ALDH1A1 (0.74) CDK2MEN1ALDH1A1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3334 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3494396-B1 CHEMILUMINESCENT AND FLUORESCENT SUBSTRATE PADS AND USES THEREOF PIERCE BIOTECHNOLOGY INC (US) 2025-06-11 EP claimed
US-12109297-B2 Process for treating keratin fibers employing an anhydride acrylic polymer in oily dispersion and an amine compound L'OREAL (FR) 2024-10-08 US claimed
US-20240315965-A1 COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS Natural Extraction Systems, LLC (US) 2024-09-26 US claimed
US-12084411-B2 Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2024-09-10 US claimed
US-20240261210-A1 PROCESS FOR TREATING KERATIN FIBERS EMPLOYING AN ANHYDRIDE ACRYLIC POLYMER IN OILY DISPERSION AND AN AMINE COMPOUND L'OREAL (FR) 2024-08-08 US claimed
EP-3331546-B1 CXCR4 INHIBITOR FOR THE TREATMENT OF CANCER BIOKINE THERAPEUTICS LTD (IL) 2023-10-04 EP claimed
US-20230293452-A1 RESTORING PHYSIOLOGY IN IRON-DEFICIENT ORGANISMS USING SMALL MOLECULES THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2023-09-21 US claimed
US-11648251-B2 TTP phosphorylation as a biomarker in targeted therapy KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTRE (SA) 2023-05-16 US claimed
US-20230089351-A1 METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES Natural Extraction Systems, LLC (US) 2023-03-23 US claimed
WO-2022182527-A1 COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS Natural Extraction Systems, LLC (US) 2022-09-01 WO claimed
WO-1992020332-A1 PHARMACEUTICAL COMPOSITION COMPRISING PURPUROGALLIN USEFUL AS AN ANTIOXIDANT AND CYTOPROTECTIVE AGENT WU TAI WING (CA) 1992-11-26 WO claimed
EP-0460078-A1 PHARMACEUTICALLY ACTIVE AGENTS THAT IMPEDE AMYLOID FORMATION IN VIVO AVERBACK, Paul (CA) 1991-12-11 EP claimed
WO-1990009789-A2 PHARMACEUTICALLY ACTIVE AGENTS THAT IMPEDE AMYLOID FORMATION IN VIVO AVERBACK PAUL (CA) 1990-09-07 WO claimed
EP-0290442-A4 PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS. CHEMEX PHARMACEUTICALS INC (US) 1990-07-03 EP claimed
US-4906549-A Positive-working photoresist composition with quinone diazide sulfonic acid ester and novolac made from m-cresol, p-cresol and aliphatic phenol with 2-6 carbon atoms TOKYO OHKA KOGYO CO., LTD. (JP) 1990-03-06 US claimed
EP-0290442-A1 PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS CHEMEX PHARMACEUTICALS, INC. (US) 1988-11-17 EP claimed
WO-1988003805-A1 PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS CHEMEX PHARMACEUTICALS, INC. (US) 1988-06-02 WO claimed
EP-0020895-B1 A PARTIAL THROMBOPLASTINE BEHRINGWERKE Aktiengesellschaft (DE) 1984-05-23 EP claimed
US-4181545-A POT LIFE OF HYDROXY POLYBUTADIENE UNITED TECHNOLOGIES CORPORATION (US) 1980-01-01 US claimed
US-4109051-A POLYHYDROXY AROMATIC COATING COMPOSITIONS FOR REINFORCING GLASS FIBERS USED IN CEMENTITIOUS PRODUCTS PILKINGTON BROTHERS LIMITED (GB) 1978-08-22 US claimed